Evidence map›Paper›PMID 28337202›Full record

ArticleFrontiers in immunology2017

Murine Cytomegalovirus Disrupts Splenic Dendritic Cell Subsets

William T Nash, Alyssa L Gillespie, Michael G Brown

Abstract read
In one paragraph

Article in Frontiers in immunology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

William T NashDepartment of Microbiology, Immunology, and Cancer Biology, School of Medicine, University of Virginia, Charlottesville, VA, USA; Beirne B. Carter Center for Immunology Research, School of Medicine, University of Virginia, Charlottesville, VA, USA; Division of Nephrology, Department of Medicine, University of Virginia, Charlottesville, VA, USA.
Alyssa L GillespieBeirne B. Carter Center for Immunology Research, School of Medicine, University of Virginia, Charlottesville, VA, USA; Division of Nephrology, Department of Medicine, University of Virginia, Charlottesville, VA, USA.
Michael G BrownDepartment of Microbiology, Immunology, and Cancer Biology, School of Medicine, University of Virginia, Charlottesville, VA, USA; Beirne B. Carter Center for Immunology Research, School of Medicine, University of Virginia, Charlottesville, VA, USA; Division of Nephrology, Department of Medicine, University of Virginia, Charlottesville, VA, USA.

Funding

INTERDISCIPLINARY TRAINING PROGRAM IN IMMUNOLOGYT32AI007496 · NIAID · UNIVERSITY OF VIRGINIA CHARLOTTESVILLE · PI Michael G. Brown, Coleen A McNamara · 1995 to 2026
$10.2M
Molecular study of mouse viral resistance mechanisms.R01AI050072 · NIAID · UNIVERSITY OF VIRGINIA CHARLOTTESVILLE · PI BROWN, MICHAEL G · 2001 to 2021
$7.1M
Kidney Disease and InflammationT32DK072922 · NIDDK · UNIVERSITY OF VIRGINIA · PI OKUSA, MARK DOUGLAS · 2006 to 2020
$2.6M
MHC regulation of NK cell mediated virus immunityR01AI082024 · NIAID · UNIVERSITY OF VIRGINIA · PI BROWN, MICHAEL G · 2010 to 2013
$1.5M
NIAID NIH HHS R01 AI050072NIAID NIH HHS R01 AI082024NIAID NIH HHS T32 AI007496NIDDK NIH HHS T32 DK072922
6 · The paper itself

Abstract

Dendritic cells (DC) are well-known modulators of immunity. This heterogeneous population is composed of defined subsets that exhibit functional specialization and are critical in initiating responses to pathogens. As such, many infectious agents employ strategies to disrupt DC functioning in attempts to evade the immune system. In some instances, this manifests as an outright loss of these cells. Previous work has suggested that, in the absence of an efficient natural killer (NK) cell response, murine cytomegalovirus (MCMV) induces large amounts of interferon (IFN)-I. This heightened IFN-I response is thought to contribute to conventional DC (cDC) loss and delayed development of T cell immunity. However, the precise role of IFN-I in such cDC loss remains unclear. We investigated the effects of licensed NK cells and IFN-I signaling on splenic cDC subsets during MCMV infection and found that a licensed NK cell response partially protects cDC numbers, but does not prevent increases in serum IFN-I. This suggested that high residual IFN-I could contribute to cDC loss. Therefore, we used multiple strategies to modulate IFN-I signaling during MCMV infection including plasmacytoid DC depletion, IFN-I receptor (IFNAR) blockade, and genetic ablation of IFNAR expression. Interestingly, restriction of IFN-I signals did not substantially preserve either CD8

Indexed as

CD4+ DCCD8+ DCDC lossDN DCIFN-Ilicensed NK cellMCMVspleen DC subsets

Identifiers

PMID28337202
PMCPMC5343017

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.